We have shown that the AdRGD-PG vector is an effective means of transferring the human IFNβ cDNA to human melanoma cell lines, resulting in extensive cell death in vitro and nearly complete tumor inhibition when applied in a model of in situ gene therapy using SK-MEL-147 cells. The gene discussed is IFNB1; the disease is neoplasm.